|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02348 DAWNRAYS PHARMA
Nominal 
1.160 +0.010 (+0.870%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 2,611 | -4.673% | 2,739 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,123,763 | 0.713% | 1,115,805 | 1,191,266 | 1,032,131 | 657,396 |
| Land & other Lease Assets | 104,644 | 3.142% | 101,456 | 109,603 | 110,755 | 124,553 |
| Intangible Assets | 542,081 | 2.383% | 529,465 | 536,185 | 528,171 | 447,874 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 25,345 | 87,250 | 98,669 |
| Other Non-current Assets | 33,936 | -77.819% | 152,998 | 66,249 | 70,215 | 26,529 |
| 1,807,035 | -5.016% | 1,902,463 | 1,928,648 | 1,828,522 | 1,355,021 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 308,241 | 46.012% | 211,107 | 241,746 | 203,476 | 246,028 | |
| Trade Receivables | 267,886 | -16.805% | 321,996 | 402,850 | 346,778 | 330,747 | |
| Cash & Bank Balances | 1,158,261 | 27.868% | 905,826 | 811,682 | 577,744 | 730,986 | |
| Other Current Assets | 456,850 | 62.426% | 281,267 | 285,139 | 288,775 | 240,953 | |
| Assets Held for Sale | 11,003 | -- | 0 | 2,578 | 94,263 | 0 | |
| 2,202,241 | 28.023% | 1,720,196 | 1,743,995 | 1,511,036 | 1,548,714 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 221,560 | 36.630% | 162,161 | 224,073 | 143,212 | 157,613 | ||
| S-T Debt & Leases | 31,024 | -74.238% | 120,424 | 7,968 | 21,993 | 924 | ||
| Other Current Liabilities | 302,019 | -21.829% | 386,355 | 700,016 | 531,899 | 321,371 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 554,603 | -17.092% | 668,940 | 932,057 | 697,104 | 479,908 | |||
| Net Current Assets | 1,647,638 | 56.730% | 1,051,256 | 811,938 | 813,932 | 1,068,806 | ||
| Total Assets Less Current Liabilities | 3,454,673 | 16.960% | 2,953,719 | 2,740,586 | 2,642,454 | 2,423,827 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 3,695 | 3487.379% | 103 | 444 | 1,527 | 2,025 | |||
| Other Non-current Liabilities | 124,310 | 31.709% | 94,382 | 90,275 | 243,066 | 238,210 | |||
| 128,005 | 35.477% | 94,485 | 90,719 | 244,593 | 240,235 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 80,530 | 0.093% | 80,455 | 80,389 | 80,370 | 81,072 | ||||
| Reserves | 3,243,738 | 16.925% | 2,774,201 | 2,561,567 | 2,300,344 | 2,089,431 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 3,324,268 | 16.451% | 2,854,656 | 2,641,956 | 2,380,714 | 2,170,503 | ||||
| Non-controlling Interests | 2,400 | -47.575% | 4,578 | 7,911 | 17,147 | 13,089 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 3,326,668 | 16.348% | 2,859,234 | 2,649,867 | 2,397,861 | 2,183,592 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 62,935 | 111,303 | 239,908 | 252,590 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 23/04/2025 15:08 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 564,940 |
| %Change | 73.294% |
| EPS / (LPS) | RMB 0.375 |
| NBV Per Share (¥) | RMB 2.213 |